M

Moyes Eye Center | Clinical Research Department

Research site

(Unclaimed)

Location

5151 NW 88th Street, Kansas City, Missouri, United States of America

Site insights

Top conditions

Top treatments

AR-15512

AGN-190584

Systane

AGN-223575

iodine

PVP

Pilocarpine HCl

Bimatoprost

Iodine

Tavilermide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease (UplighTED)

This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod P...

Enrolling

Thyroid Eye Disease

Other: Placebo PH20 SC

Combination Product: Efgartigimod PH20 SC

Clareon PanOptix Pro vs. Clareon PanOptix - Study A

The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™...

Active, not recruiting

Presbyopia

Aphakia

Procedure: Cataract surgery

Device: CPO IOL

Clareon PanOptix Pro vs. Clareon PanOptix - Study B

The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™...

Active, not recruiting

Presbyopia

Aphakia

Procedure: Cataract Surgery

Device: CPO Pro IOL

Hydrus® Microstent New Enrollment Post-Approval Study (CONFIRM)

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24...

Enrolling

Primary Open Angle Glaucoma

Device: Hydrus Microstent

Device: Monofocal IOL